Nutrition, Metabolism & Cardiovascular Diseases
Volume 18, Issue 2 , Pages 121-126 , February 2008

QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction

Received 17 March 2006 ,Revised 1 September 2006 ,Accepted 11 September 2006.

References 

  1. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40:954–960
  2. Perkiomaki JS, Koistinen MJ, Yli-Mayry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol. 1995;26:174–179
  3. Cardoso CR, Salles GF, Deccache W. Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diabetes Complications. 2003;17:169–178
  4. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994;343:742
  5. Robillon JF, Sadoul JL, Benmerabet S, Joly-Lemoine L, Fredenrich A, Canivet B. Assessment of cardiac arrhythmic risk in diabetic patients using QT dispersion abnormalities. Diabetes Metab. 1999;25:419–423
  6. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85
  7. Figueredo EJ, Ohnishi Y, Yoshida A, Yokoyama M. Usefulness of beat-to-beat QT dispersion fluctuation for identifying patients with coronary heart disease at risk for ventricular arrhythmias. Am J Cardiol. 2001;88:1235–1239
  8. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353–370
  9. Sakabe K, Ikeda T, Sakata T, Kawase A, Kumagai K, Tezuka N, et al. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study. Jpn Heart J. 2001;42:451–457
  10. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation. 1980;62:212–217
  11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–1082
  12. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens. 2005;18:191–196
  13. Yuan S, Wohlfart B, Olsson SB, Blomstrom-Lundqvist C. The dispersion of repolarization in patients with ventricular tachycardia: a study using simultaneous monophasic action potential recordings from two sites in the right ventricle. Eur Heart J. 1995;16:68–76
  14. Schinkel AF, Bountioukos M, Poldermans D, Elhendy A, Valkema R, Vourvouri EC, et al. Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy. Am J Cardiol. 2003;92:712–715
  15. Bountioukos M, Schinkel AF, Poldermans D, Rizzello V, Vourvouri EC, Krenning BJ, et al. QT dispersion correlates to myocardial viability assessed by dobutamine stress echocardiography in patients with severely depressed left ventricular function due to coronary artery disease. Eur J Heart Fail. 2004;6:187–193
  16. Takebayashi K, Sugita R, Tayama K, Aso Y, Takemura Y, Inukai T. The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2003;111:351–357
  17. Takahashi N, Nakagawa M, Saikawa T, Watanabe M, Ooie T, Yufu K, et al. Regulation of QT indices mediated by autonomic nervous function in patients with type 2 diabetes. Int J Cardiol. 2004;96:375–379
  18. Hashimoto N, Musha H, Ozawa A, Imai Y, Kawasaki K, Miyazu O, et al. Relationship between infarction location and size to QT dispersion in patients with chronic myocardial infarction. Jpn Heart J. 2002;43:455–461
  19. Chapman N, Mayet J, Ozkor M, Lampe FC, Thom SA, Poulter NR. QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population. Am J Hypertens. 2001;14:455–462
  20. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;4:362–367
  21. Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil. 2005;12:363–368
  22. Abildstrom SZ, Jensen BT, Agner E, Torp-Pedersen C, Nyvad O, Wachtell K, et al. BEAT Study Group. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol. 2003;14:174–175
  23. Antoniucci D, Valenti R, Migliorini A, Parodi G, Moschi G, Memisha G, et al. Impact of insulin-requiring diabetes mellitus on effectiveness of reperfusion and outcome of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2004;93:1170–1172
  24. Tentolouris N, Matsagura M, Psallas M, Chatzizacharias A, Fotia M, Arvanitis M, et al. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin. Exp Clin Endocrinol Diabetes. 2005;113:298–301
  25. Ranade V, Molnar J, Khokher T, Agarwal A, Mosnaim A, Somberg JC. Effect of angiotensin-converting enzyme therapy on QT interval dispersion. Am J Ther. 1999;6:257–261
  26. Pittenger B, Gill EA, Holcslaw TL, Bristow MR. Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy. Am J Cardiol. 2004;94:1459–1462

☆ Portions of the results were presented at the European Society of Cardiology Congress 2005, Stockholm, Sweden, September 3–7, 2005.

PII: S0939-4753(06)00199-2

doi: 10.1016/j.numecd.2006.09.002

Nutrition, Metabolism & Cardiovascular Diseases
Volume 18, Issue 2 , Pages 121-126 , February 2008

Article Tools